Jan 13, 2022 / 03:30PM GMT
David Choi -
Good morning. Welcome to day 4 and the final day of the 40th JPMorgan Healthcare Conference. My name is David Choi, and I'm an associate in the JPMorgan Healthcare Investment Banking Group.
Before I introduce you to our next company, I'd like to draw your attention to the blue box at the bottom of your web page. If you could submit all your questions through that link, it'd be much appreciated. With that, I'm pleased to introduce you to NGM Biopharmaceuticals. We have David Woodhouse, CEO of the company, on behalf of the company. With that, over to you, David.
David J. Woodhouse - NGM Biopharmaceuticals, Inc. - CEO & Director
Thank you, David, and thank you all for joining the presentation this morning. At NGM, we're explorers on the frontier of life-changing science, and our vision is to make lasting scientific contributions that improve human life. Today, I'm looking forward to giving you an overview of the company and what we're looking forward to this year. If you take one thing away from today, it is that our platform and pipeline is
NGM Biopharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers